Friedrich Heinrich Karl La Motte-Fouquë, Hermann Kletke,
"Mit einer Biographie Fouquë's von Jul. Ed. Hitzig und einem Vorwort und biographischen Notizen von Dr. H. Kletke, Herausgegeben von Albertine Baronin ...
1848 - Gale Group | NCCO Corvey
Biao Yuan, Pan Wu, Changjun Liu, Jian He, Wei Jiang,
The challenge of separating and recovering V(V) and Cr(VI) from wastewater is critical for environmental protection and industrial productivity due to the chemical similarities. In this study, a novel ... 3 m2/g. The maximum adsorption capacities of V(V) and Cr(VI) were 222 and 123 mg/ ... was thoroughly investigated confirming that the adsorption of V(V) and Cr(VI) on amorphous hydrous ZrO2 (AHZOs) ... than those for the main existing form HCrO4-. V(V) replaced the adsorbed Cr(VI) during competitive adsorption ...
Tópico(s): Minerals Flotation and Separation Techniques
2025 - Elsevier BV | Separation and Purification Technology
Title from first words of text. At head of text: Iesus Maria. Dated and signed (leaf 10): De Madrid, &c. catorze de enero de mil y [sei]scientos y ocho, ...
0000 - Gale Group | The Making of Modern World
Jian Zhang, Huitao Zhou, Heilong Mi,
... ε 2 Δ u + ε b → ⋅ ∇ u + u + V ( x ) v = H v ( u , v ) in R N , − ε 2 Δ v − ε b → ⋅ ∇ v + v + V ( x ) u = H u ( u , v ) in R N , \left\{\begin{array}{l}-{\varepsilon }^{ ... u+\varepsilon \overrightarrow{b}\cdot \nabla u+u+V\left(x)v={H}_{v}\left(u,v)\ ...
Tópico(s): Advanced Mathematical Modeling in Engineering
2024 - De Gruyter | Advances in Nonlinear Analysis
Book.
0000 - Gale Group | Sabin
Shraddha Chavan, Bhoomika Yadav, R. D. Tyagi, Jonathan W.C. Wong, Patrick Drogui,
... N NaOH at a concentration of 0–30% (v/v), 30–100 °C for 0–120 min. Furthermore, ... after acidic or alkaline pre-treatments (0–1% v/v α-amylase and 0–1% v/v amyloglucosidase-AMG) while maintaining a constant pH 5, ... min. Pre-treatment of KW with acid (15% v/v 4 N HCl in water) at temperature 100 ° ... followed by enzymatic hydrolysis, i.e., 0.6% (v/v) α-amylase and 0.4% (v/v) amyloglucosidase ( ...
Tópico(s): Advanced Cellulose Research Studies
2024 - Elsevier BV | Biochemical Engineering Journal
Carnot, Lazare, Lagarde, Joseph-Jean, baron,
At head of title: No. 506. Bulletin des lois, No. 129. Au nom de la République française. Signed: Carnot, président; par le Directoire exécutif le secrétaire- ...
0000 - Gale Group | The Making of Modern World
Karim Chamie, Sam S. Chang, Eugene V. Kramolowsky, Mark L. Gonzalgo, Megan Huang, Paul Bhar, Patricia Spilman, Lennie Sender, Sandeep K. Reddy, Patrick Soon‐Shiong,
... Editorial Comment Karim Chamie, Sam S. Chang, Eugene V. Kramolowsky, Mark L. Gonzalgo, Megan Huang, Paul Bhar, ... Center, Vanderbilt University Medical Center, Nashville, Tennessee , Eugene V. KramolowskyEugene V. Kramolowsky Virginia Urology, Richmond, Virginia , Mark L. GonzalgoMark ... at month 3), and for those with CR vs without a CR at 0, 6, and 12 ... Ta). BCG only (reference), BCG + other therapy. CR vs no CR not performed for cohort B. QLQ- ... reference; TURBT, transurethral resection of bladder tumor. White vs non-White (ref). BCG only. CIS vs CIS/ ...
Tópico(s): Epigenetics and DNA Methylation
2024 - Lippincott Williams & Wilkins | Urology Practice
Letter enclosing V/13 and V/14. Pamphlets. Munitions. MUN. V/12. Book.
0000 - Gale Group | ArchivesUnbound Women-War
C.O. Rees, Sophie Thomas, Anna De Boer, Yizhou Huang, Brunella Zizolfi, Virginia Foreste, Attilio Di Spiezio Sardo, Nikos Christoforidis, Hubertus A.A.M. van Vliet, Massimo Mischi, B.C. Schoot,
... with a higher amplitude (0.087 ± 0.042 vs. 0.050 ± 0.018), lower frequency and velocity (1.49 ± 0.22 vs. 1.68 ± 0.25 contractions/min, and 0.65 ± 0.18 vs. 0.88 ± 0.29 mm/s, respectively), and reduced contraction coordination (0.34 ± 0.08 vs. 0.26 ± 0.17), in the late luteal phase, with higher amplitude (0.050 ± 0.022 vs. 0.035 ± 0.013), lower velocity (0.51 ± 0.11 vs. 0.65 ± 0.13 mm/s), and reduced contraction coordination (0.027 ± 0.06 vs. 0.18 ± 0.07), and in the midfollicular phase, with decreased frequency (1.48 ± 0.21 vs. 1.69 ± 0.16 contractions/min) in patients ...
Tópico(s): Gynecological conditions and treatments
2024 - Elsevier BV | Fertility and Sterility
... is added, an appendix of official naval documents, v. 1-2: 1813. Philadelphia, M. Thomas, 1816. 2 v. : ports. 22 1/2 cm. monthly. Added t.- ...
0000 - Gale Group | Sabin
Produção Nacional
Revisado por pares
María‐Victoria Mateos, Paweł Robak, Marek Hus, Zhongjun Xia, Vera Zherebtsova, Christopher Ward, P. Joy Ho, Roman Hájek, Kihyun Kım, Meletios Α. Dimopoulos, Claudio Cerchione, Antonio Riccio, Astrid McKeown, Rachel Rogers, Hena Baig, Lydia Eccersley, Sumita Roy–Ghanta, Joanna Opalinska, Vânia Hungria,
... evaluating the efficacy and safety of BVd triplet vs SoC triplet, DVd, in patients (pts) with RRMM ... BVd: B 2.5 mg/kg IV Q3W + V 1.3 mg/m 2 (D1, 4, 8, ... 8, Q3W, and Q4W from C 9 on); V and d schedules were the same. The primary ... 6 mo (95% CI, 28.4 mo-NR) vs 13.4 mo (11.1-17.5 mo) ... 95% CI, 30.5 mo-NR) for BVd vs 17.8 mo (13.8-23.6 mo) ... were reported in 50% of pts in BVd vs 37% in DVd arm. Ocular AEs were more frequent on BVd vs DVd (79% vs 29%) and were manageable. Conclusions: The DREAMM-7 head-to-head study of BVd vs DVd demonstrated statistically significant PFS benefit of BVd ...
Tópico(s): Cancer therapeutics and mechanisms
2024 - Lippincott Williams & Wilkins | Journal of Clinical Oncology
... the Chairman and Members of the Central Joint V.A.D. Committee. Joint Women's V.A.D. Committee. Miscellaneous reforms, etc. British Red ...
1917 - Gale Group | ArchivesUnbound Women-War
Francesco Di Bello, Carolin Siech, Mario de Angelis, Natali Rodriguez Peñaranda, Zhe Tian, Jordan A. Goyal, Claudia Collà Ruvolo, Gianluigi Califano, Massimiliano Creta, Fred Saad, Shahrokh F. Shariat, Alberto Briganti, Felix K. H. Chun, Salvatore Micali, Nicola Longo, Pierre I. Karakiewicz,
... patients were younger (≤70 years of age; 75 vs. 53%), more frequently female (28 vs. 19%), and more frequently harbored Charlson Comorbidity Index ≥3 (56 vs. 18%). Of paraplegic vs. non-paraplegic RC patients, 141 versus 15,112 (76 vs. 60%) experienced overall complications, 38 versus 2794 (21 vs. 11%) pulmonary complications, 36 versus 3525 (19 vs. 14%) genitourinary complications, 33 versus 3087 (18 vs. 12%) intraoperative complications, 21 versus 1035 (11 vs. 4%) infections, and 17 versus 1343 (9 vs. 5%) wound complications, while 62 versus 6267 (34 ...
Tópico(s): Urinary and Genital Oncology Studies
2024 - Springer Science+Business Media | Annals of Surgical Oncology
Agenda Joint Women's V.A.D. Committee. Joint Women's V.A.D. Committee Minutes. British Red Cross Society. 6 Mar. 1916. B.R. ...
1916 - Gale Group | ArchivesUnbound Women-War
Produção Nacional
Revisado por pares
Lisa Licitra, Makoto Tahara, Kevin J. Harrington, Mivael Olivera, Yi Guo, Sercan Aksoy, Min Fang, Bogdan Żurawski, Tibor Csőszi, Mikhail Klochikhin, Tainá B. Oliveira, Shunji Takahashi, Muh‐Hwa Yang, Paul Swiecicki, Karen O’Hara, John Paul Shen, Andrew Z. Wang, Burak Gümüşçü, K.C. Benjamin, Robert I. Haddad,
... CI: 5.1-7.2) for len + pembro vs 2.8 mo (95% CI: 2.0-4. ... CI: 38.6-53.7) for len + pembro vs 25.4% (95% CI: 19.1-32.6) ... range, 1.3-30.9) for len + pembro vs NR (1.2-32.2) for placebo + pembro. ... CI: 13.2-17.0) for len + pembro vs 17.9 mo (95% CI: 13.8-21. ... had grade ≥3 treatment-related adverse events (TRAEs) vs 45 (17.8%) on placebo + pembro, 28% vs 8% pts discontinued any treatment due to TRAEs, and 7 vs 3 pts had treatment-related deaths, respectively. Conclusion ... CI: 5.1-7.2) for len + pembro vs 2.8 mo (95% CI: 2.0-4. ... CI: 38.6-53.7) for len + pembro vs 25.4% (95% CI: 19.1-32.6) ...
Tópico(s): Lung Cancer Treatments and Mutations
2024 - Elsevier BV | International Journal of Radiation Oncology*Biology*Physics
Leaflet: Nethercourt, V.A.D. Birthday Sports Programme. Nethercourt, Ramsgate, Kent 2 V.A.D. Hospital. British Red Cross Society. 14 ...
1917 - Gale Group | ArchivesUnbound Women-War
F. Romanelli, Domenico Abate, E. Acampora, D. Agguiaro, R. Agnello, P. Agostinetti, M. Agostini, Alex Aimetta, R. Albanese, G. Alberti, Martin Albino, E. Alessi, S. Almaviva, M. Alonzo, R. Ambrosino, P. Andreoli, M. Angelone, M. Angelucci, C. Angioni, A. Angrisani Armenio, P. Antonini, D. Aprile, G. Apruzzese, M. Aquilini, G. Aragone, P. Arena, M. Ariola, G. Artaserse, L. Aucone, A. Augieri, F. Auriemma, J. Ayllon Guerola, Nicolò Badodi, B. Baiocchi, L. Balbinot, Chiara Baldacchini, A. Balestri, T. Barberis, G. Barone, L. Barucca, M. Baruzzo, S. Begozzi, Valerio G. Belardi, F. Belli, A. Belpane, F. Beone, Sofia Bertolami, S. Bianucci, Stefano Bifaretti, Stefano Bigioni, W. Bin, P. Boccali, B. Boeswirth, E. Bogazzi, Radu Bojoi, S. Bollanti, T. Bolzonella, F. Bombarda, M. Bonan, N. Bonanomi, Aldo Bonaventura, L. Boncagni, M. Bonesso, D. Bonfiglio, R. Bonifetto, D. Bonomi, D. Borgogno, Tommaso Borzone, S. Botti, Emre B. Boz, F. Braghin, M. Brena, S. Brezinsek, M. Brombin, A. Bruschi, Sara Buonocore, P. Buratti, P. Buratti, D. Busi, G. Calabró, Marzia Caldora, G Calvo, Gabriele Camera, R. Campana, Silvia Candela, Valentina Candela, F. Cani, L Cantone, F. Capaldo, S. Cappello, M. Caponero, S. Carchella, A. Cardinali, D. Carnevale, L. Carraro, Carlo Carrelli, Valentina Casalegno, I. Casiraghi, C. Castaldo, A. Castaldo, G. Castro, Andrea Carpignano, F. Causa, R. Cavazzana, M. Cavedon, M. Cavenago, M. Cecchini, S. Ceccuzzi, G. Celentano, L. Celona, C. Centioli, Giulia Valeria Centomani, S. Cesaroni, Andrea Gaetano Chiariello, R. Chomicz, C. Cianfarani, Filippo Cichocki, Marcello Cinque, Andrea Cioffi, Marco Ciotti, M. Cipriani, S. Ciufo, Vincenzo Claps, G. Claps, V. Coccorese, D. Coccorese, A. Colangeli, Thomas Coltella, F. Consoli, F. Cordella, Davide Corradini, Orozimbo Alves Costa Filho, Francesco Crea, A. Cremona, F. Crescenzi, F. Crisanti, G. Cristofari, G. Croci, A. Cucchiaro, Domenic D’Ambrosio, Marta Dal Molin, M. Dalla Palma, Francis C. Dane, C. Day, M. De Angeli, V. De Leo, Riccardo De Luca, Eliana De Marchi, G. De Marzi, G. Masi, E. Nardi, C. De Piccoli, G. De Sano, M. De Santis, G. De Tommasi, A. Del Nevo, A. Delfino, A. della Corte, P. Deodati, S. Desiderati, E. Di Ferdinando, Massimo Florio, G. Di Gironimo, Luigi Emanuel di Grazia, V. Di Marzo, Franco Di Paolo, E. Di Pietro, M. Di Pietrantonio, Matteo Di Prinzio, Alessia Di Silvestre, A. Di Zenobio, R. Dima, A. Domenichelli, A. Doria, G. Dose, Sara Dubbioso, Sandra Dulla, I. Duran, Marica Eboli, M. Elitropi, E. Emanuelli, B. Esposito, P. Ettorre, Claudia Fabbri, F. Fabbri, M. Fadone, M Faggiano, F. FALCIONI, Matteo Valerio Falessi, F. Fanale, Pierluigi Fanelli, A. Fassina, A. Fassina, M. Favaretto, G. Del Favero, Monica Ferraris, F. Ferrazza, C. Ferretti, A. Ferro, N. Ferron, Chiarasole Fiamozzi Zignani, L. Figini, F. Filippi, M. Filippini, A. Fimiani, M. Fincato, F. Fiorenza, D. Fiorucci, D. Flammini, F. Flora, N. Fonnesu, P. Franz, L. Frassinetti, A. Frattolillo, R. Freda, R. Fresa, Alessandro Frescura, P. Frosi, M. Fulici, M. Furno Palumbo, V. Fusco, P. Fusco, L. Gabellier, Paolo Gaetani, E. Gaio, Eleonora Gajetti, Paolo Gaetani, A. Galatà, J. Galdón-Quiroga, D.L. Galindo Huertas, S. Gammino, Giada Gandolfo, S. Garavaglia, J. Garcı́a López, M. García-Muñoz, P. Gaudio, M. Gelfusa, G. Gervasini, Lorenzo Giannini, M. Giarrusso, C. Gil, F. Giorgetti, E. Giovannozzi, G. Giruzzi, L. Giudicotti, M. Gobbin, G. Gorini, G. Granucci, D. Grasso, T. Grasso, S. Grazioso, H. Greuner, G. Griva, G. Grosso, S. Guerini, J. Gunn, V. Hauer, Javier Hidalgo Salaverri, M. Hoppe, M. Houry, M. Hoelzl, Andrea Iaboni, М. Иафрати, Antonio Iaiunese, Vito Imbriani, D. Indrigo, M. Nocente, F. Koechl, Boštjan Končar, A. Kryzhanovskyy, L. Laguardia, Alessandro Lampasi, C. Lanchi, Francesca Giovanna Lanzotti, Antonio Lanzotti, M. Laquaniti, F. Leone, J. Li, M. Libè, Fabrizio Lisanti, Davide Liuzza, Francesca Locati, R. Lombroni, R. Lorenzini, Pierdomenico Lorusso, Lorella Lotto, J. Loureiro, F. Lucca, T. Luda, P. Maccari, G. Maddaluno, S. Magagnino, G. Manca, A. Mancini, P. Mandalà, B. Mandolesi,
Abstract An overview is presented of the progress since 2021 in the construction and scientific programme preparation of the Divertor Tokamak Test (DTT) facility. Licensing for building construction has been granted at the end of 2021. Licensing for Cat. A radiologic source has been also granted in 2022. The construction of the toroidal field magnet system is progressing. The prototype of the 170 GHz gyrotron has been produced and it is now under test on the FALCON facility. The design of the vacuum ...
IOP Publishing
... is added, an appendix of official naval documents, v. 1-2: 1813. Philadelphia, M. Thomas, 1816. 2 v. : ports. 22 1/2 cm. monthly. Added t.- ...
0000 - Gale Group | Sabin
Tanush Gupta, James T. DeVries, Fahad Gilani, Ansar Hassan, Cathy S. Ross, Harold L. Dauerman,
... receiving TAVR in 2020.3Prosperi-Porta G. Nguyen V. Willner N. et al.Association of age and ... Scopus (40) Google Scholar,3Prosperi-Porta G. Nguyen V. Willner N. et al.Association of age and ... Scopus (3) Google Scholar Temporal trends in TAVR vs SAVR utilization were compared according to the 3 ... body mass index, left ventricular ejection fraction, urgent vs elective clinical status, New York Heart Association class ... 7 ± 4.6 years in the TAVR group vs 58.1 ± 6.0 years in the SAVR ... Mortality (STS-PROM) was 3.5 ± 3.1% vs 1.5 ± 1.4% in the TAVR vs ...
Tópico(s): Aortic Disease and Treatment Approaches
2024 - Elsevier BV | Journal of the Society for Cardiovascular Angiography & Interventions